Anna Adachi-Mejia, PhD, who was recently appointed director of the The Dartmouth Institute-based Health Promotion Research Center at Dartmouth (HPRCD), reflects on her work and HPRCD’s role in addressing some of today’s pressing public health concerns.
Post Tagged with: "Q&A"
Understanding Scleroderma’s ‘Social Network’ May Lead to New Treatments
With funding from the Falk Foundation, Mike Whitfield’s lab is mapping which genes interact with each other in the debilitating disease scleroderma. Their discoveries reveal new avenues for treatment.